Cephalon Reaches New 52-Week High (CEPH)

NEW YORK ( TheStreet) -- Cephalon Inc (Nasdaq: CEPH) hit a new 52-week high Friday as it is currently trading at $81.12, above its previous 52-week high of $81.11 with 1.5 million shares traded as of 12:19 p.m. ET. Average volume has been 3.2 million shares over the past 30 days.

Cephalon has a market cap of $6.3 billion and is part of the health care sector and drugs industry. Shares are up 31.1% year to date as of the close of trading on Thursday.

Cephalon, Inc., a biopharmaceutical company, engages in discovering and developing medicines for central nervous system disorders, pain, oncology, inflammatory disease, and regeneration worldwide. The company has a P/E ratio of 15.9, above the average drugs industry P/E ratio of 11.9 and below the S&P 500 P/E ratio of 17.7.
  • Practice your CEPH trading strategies and win cash in our stock game.

TheStreet Ratings rates Cephalon as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full Cephalon Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Jim Cramer: Schlumberger Predicted the Rise in Oil Prices

Jim Cramer: Schlumberger Predicted the Rise in Oil Prices

Jim Cramer on Zillow's New Business: Buying and Selling Homes

Jim Cramer on Zillow's New Business: Buying and Selling Homes

Jim Cramer on the Markets: It's Natural to Have Some Profit Taking

Jim Cramer on the Markets: It's Natural to Have Some Profit Taking

Video: As Trade Worries Subside, Expect a 'Relief Rally' in Stocks

Video: As Trade Worries Subside, Expect a 'Relief Rally' in Stocks

Stocks Trade Mixed Amid Progress on U.S.-China Trade; Dow Turns Lower

Stocks Trade Mixed Amid Progress on U.S.-China Trade; Dow Turns Lower